FDA Import Refusal SCS-7901634-3/11/1 — Novo Nordisk Inc.

Novo Nordisk Inc. — FEI 2244771

The FDA refused shipment SCS-7901634-3/11/1 from Novo Nordisk Inc. (United States) on Dec 2, 2021. The refused product falls under Drugs and Biologics — GLUCAGON (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal details

Date
Dec 2, 2021
Country
United States
Product Category
Drugs and Biologics
Product Code
61PCP10 GLUCAGON (ANTI-DIABETIC)
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.